EGFR and neoplasm: Subsequently, they conducted co-culturing experiments by introducing MUC1-CAR-T cells and EGFR VIII-CAR-T cells to their respective tumor organoids, thereby verified the anti-tumorigenic effect of these two innovative CAR-T cell targets.